Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

23.47

+0.91 (4.03%)

At close: Feb 6, 2026, 4:00 PM EST

23.49

+0.02 (0.09%)

After-hours: Feb 6, 2026, 4:10 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EMPAVELI Revenue	90.67M	98.09M
SYFOVRE Revenue	599.54M	611.86M
Total Product Revenue	690.21M	709.95M
Licensing and Other Revenue	326.18M	71.41M
Revenue (Total)	1.02B	781.37M

Updated Oct 30, 2025. Data Source: Fiscal.ai.